Koen van de Wetering

4.4k citations

54 papers · 3.1k indexed · h-index 32

Oncology top 2%
- Drug Transport and Resistance Mechanisms 23
Rheumatology top 2%
- Heterotopic Ossification and Related Conditions 12
Nephrology top 2%
Genetics top 2%
- Dermatological and Skeletal Disorders 22
Pharmacology top 1%
Pediatrics, Perinatology and Child Health
- Pharmacological Effects and Toxicity Studies 10
Cell Biology
- Skin and Cellular Biology Research 7
Endocrinology, Diabetes and Metabolism
- Alkaline Phosphatase Research Studies 7
Molecular Biology
- Amyloidosis: Diagnosis, Treatment, Outcomes 6
Infectious Diseases
- HIV/AIDS drug development and treatment 5

Co-authors: Piet Borst Noam Zelcer Robert S. Jansen András Váradi Alfred H. Schinkel Jos H. Beijnen Flóra Szeri Marcel de Haas
Cited by: Oncology Rheumatology Nephrology
Journals: Proceedings of the National Academy of Sciences (4 papers)Journal of Biological Chemistry (1 paper)Blood (1 paper)
Partner nations: Netherlands United States Hungary

In The Last Decade

Koen van de Wetering

53 papers receiving 3.0k citations

Peers

Countries citing papers authored by Koen van de Wetering

Since Specialization

Citations

This map shows the geographic impact of Koen van de Wetering's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koen van de Wetering with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koen van de Wetering more than expected).

Fields of papers citing papers by Koen van de Wetering

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koen van de Wetering. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koen van de Wetering. The network helps show where Koen van de Wetering may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Koen van de Wetering, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Koen van de Wetering Line = papers co-authored together Koen van de Wetering links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Loss of function mutation in Ank causes aberrant mineralization and acquisition of osteoblast-like-phenotype by the cells of the intervertebral disc Cell Death and Disease ·Takashi Ohnishi,Victoria Tran,Kimheak Sao,Pranay Ramteke,William Querido,Ruteja A. Barve,Koen van de Wetering,Makarand V. Risbud	2023	8
2	A new enzymatic assay to quantify inorganic pyrophosphate in plasma Analytical and Bioanalytical Chemistry ·Stefan Lundkvist,Fatemeh Niaziorimi,Flóra Szeri,Matthew Caffet,Sharon F. Terry,Gunnar Johansson,Robert S. Jansen,Koen van de Wetering	2022	4
3	Transcriptomics and Transposon Mutagenesis Identify Multiple Mechanisms of Resistance to the FGFR Inhibitor AZD4547 Cancer Research ·Sjors M. Kas,Julian R. de Ruiter,Koen Schipper,Eva Schut,Lorenzo Bombardelli,Ellen Wientjens,Anne Paulien Drenth,Renske de Korte‐Grimmerink,Sunny Mahakena,Christopher Phillips,Paul Smith,Sjoerd Klarenbeek,Koen van de Wetering,Anton Berns,Lodewyk F.A. Wessels,Jos Jonkers	2018	30
4	Negative regulation of urokinase receptor activity by a GPI-specific phospholipase C in breast cancer cells eLife ·Michiel van Veen,Elisa Matas-Rico,Koen van de Wetering,Daniela Leyton-Puig,Katarzyna M. Kedziora,Valentina De Lorenzi,Yvette Stijf‐Bultsma,Bram van den Broek,Kees Jalink,Nicolai Sidénius,Anastassis Perrakis,Wouter H. Moolenaar	2017	42
5	Abcc6 Knockout Rat Model Highlights the Role of Liver in PPi Homeostasis in Pseudoxanthoma Elasticum Journal of Investigative Dermatology ·Qiaoli Li,Joshua Kingman,Koen van de Wetering,Sami Tannouri,John P. Sundberg,Jouni Uitto	2017	43
6	Functional Rescue of ABCC6 Deficiency by 4-Phenylbutyrate Therapy Reduces Dystrophic Calcification in Abcc6–/– Mice Journal of Investigative Dermatology ·Viola Pomozi,Christopher Brampton,Flóra Szeri,Dóra Dedinszki,Eszter Kozák,Koen van de Wetering,Hi’ilani Hopkins,Ludovic Martin,András Váradi,Olivier Le Saux	2016	39
7	MRP1 mediates folate transport and antifolate sensitivity in Plasmodium falciparum FEBS Letters ·Sanna R. Rijpma,Maarten van der Velden,Albert Bilos,Robert S. Jansen,Sunny Mahakena,Frans G. M. Rüssel,Robert W. Sauerwein,Koen van de Wetering,Jan J. Koenderink	2016	10
8	N -lactoyl-amino acids are ubiquitous metabolites that originate from CNDP2-mediated reverse proteolysis of lactate and amino acids Proceedings of the National Academy of Sciences ·Robert S. Jansen,Ruben D. Addie,Remco Merkx,Alexander Fish,Sunny Mahakena,Onno B. Bleijerveld,Maarten Altelaar,Lodewijk IJlst,Ronald J. A. Wanders,Piet Borst,Koen van de Wetering	2015	95
9	ATP-binding Cassette Subfamily C Member 5 (ABCC5) Functions as an Efflux Transporter of Glutamate Conjugates and Analogs Journal of Biological Chemistry ·Robert S. Jansen,Sunny Mahakena,Marcel de Haas,Piet Borst,Koen van de Wetering	2015	52
10	Lack of ABCG2 Shortens Latency of BRCA1-Deficient Mammary Tumors and This Is Not Affected by Genistein or Resveratrol Cancer Prevention Research ·Serge A.L. Zander,Ariena Kersbergen,Wendy Sol,Maaike Gonggrijp,Koen van de Wetering,Jos Jonkers,Piet Borst,Sven Rottenberg	2012	13
11	Oral Availability of Cefadroxil Depends on ABCC3 and ABCC4 Drug Metabolism and Disposition ·Dirk R. de Waart,Koen van de Wetering,Cindy Kunne,Suzanne Duijst,Coen C. Paulusma,Ronald P.J. Oude Elferink	2011	30
12	ABCC6 does not transport vitamin K3-glutathione conjugate from the liver: Relevance to pathomechanisms of pseudoxanthoma elasticum Biochemical and Biophysical Research Communications ·Krisztina Fülöp,Qiujie Jiang,Koen van de Wetering,Viola Pomozi,Pál Szabó,Tamás Arányi,Balázs Sarkadi,Piet Borst,Jouni Uitto,András Váradi	2011	24
13	Abcc2 (Mrp2), Abcc3 (Mrp3), and Abcg2 (Bcrp1) are the main determinants for rapid elimination of methotrexate and its toxic metabolite 7-hydroxymethotrexate in vivo Molecular Cancer Therapeutics ·Maria L.H. Vlaming,Anita van Esch,Zeliha Pala,Els Wagenaar,Koen van de Wetering,Olaf van Tellingen,Alfred H. Schinkel	2009	54
14	Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides Molecular Cancer Therapeutics ·Cornelia de Wolf,Robert S. Jansen,Hiroaki Yamaguchi,Marcel de Haas,Koen van de Wetering,Jan Wijnholds,Jos H. Beijnen,Piet Borst	2008	60
15	Does the absence of ABCC6 (Multidrug Resistance Protein 6) in patients withPseudoxanthoma elasticumprevent the liver from providing sufficient vitamin K to the periphery? Cell Cycle ·Piet Borst,Koen van de Wetering,Reinier O. Schlingemann	2008	57
16	Multidrug Resistance Proteins 2 and 3 Provide Alternative Routes for Hepatic Excretion of Morphine-Glucuronides Molecular Pharmacology ·Koen van de Wetering,Noam Zelcer,Annemieke Kuil,Wouter Feddema,M. J. X. Hillebrand,Maria L.H. Vlaming,Alfred H. Schinkel,Jos H. Beijnen,Piet Borst	2007	82
17	Multidrug resistance-associated proteins 3, 4, and 5 Pflügers Archiv - European Journal of Physiology ·Piet Borst,Cornelia de Wolf,Koen van de Wetering	2006	237
18	MRP2 and 3 in health and disease Cancer Letters ·Piet Borst,Noam Zelcer,Koen van de Wetering	2006	91
19	Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides Journal of Hepatology ·Noam Zelcer,Koen van de Wetering,Rudi de Waart,George L. Scheffer,Hanns–Ulrich Marschall,Peter R. Wielinga,Annemieke Kuil,Cindy Kunne,Alexander J. Smith,Martin van der Valk,Jan Wijnholds,Ronald Oude Elferink,Piet Borst	2005	138
20	On the putative co‐transport of drugs by multidrug resistance proteins FEBS Letters ·Piet Borst,Noam Zelcer,Koen van de Wetering,B. Poolman	2005	58

About Koen van de Wetering

Koen van de Wetering is a scholar working on Rheumatology, Oncology and Genetics, having authored 54 papers that have together received 3.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (23 papers), Dermatological and Skeletal Disorders (22 papers), Heterotopic Ossification and Related Conditions (12 papers), Pharmacological Effects and Toxicity Studies (10 papers), Skin and Cellular Biology Research (7 papers), Alkaline Phosphatase Research Studies (7 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers) and HIV/AIDS drug development and treatment (5 papers). The work is most often cited by research in Oncology (1.4k citations), Rheumatology (512 citations) and Nephrology (239 citations). Koen van de Wetering has collaborated with scholars based in Netherlands, United States and Hungary. Frequent co-authors include Piet Borst, Noam Zelcer, Robert S. Jansen, András Váradi, Alfred H. Schinkel, Jos H. Beijnen, Flóra Szeri, Marcel de Haas, Sunny Mahakena and Arthur A. Bergen. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact